SCHEMBL6003637

SCHEMBL6003637

CCCCOc1ccc(-c2c[nH][c]n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 12/20 0.53
CYP19A1 P11511 12/20 0.53
CYP2C9 P11712 12/20 0.53
CYP2C19 P33261 12/20 0.53
CYP1A2 P05177 9/20 0.53
CYP3A4 P08684 6/20 0.50
ALPL P05186 1/20 0.48
HPGD P15428 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
XDH P47989 1/20 0.47
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002459 0.96 KDM4E (0.51) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL17625952 0.87 NQO1 (0.47) ALPLHPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL1317405 0.78 NPC1 (0.46) ALPLHPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL6002253 0.76 MAPT (0.36) MAPTXDH
SCHEMBL27554388 0.75 METAP2 (0.47) ALPLHPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL16439282 0.74 CYP19A1 (0.58) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL4724249 0.74 CYP19A1 (0.56) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL5583851 0.73 CYP2D6 (0.76) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL9151170 0.73 CYP2D6 (0.76) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2
SCHEMBL4919062 0.73 CYP2D6 (0.36) CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed